Beta Bionics, Inc. financial data

Symbol
BBNX on Nasdaq
Location
11 Hughes, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 29, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.5M shares
Common Stock, Shares, Outstanding 43.5M shares
Common Stock, Value, Issued 4K USD
Weighted Average Number of Shares Outstanding, Basic 43.4M shares +611%
Weighted Average Number of Shares Outstanding, Diluted 43.4M shares +611%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.2M USD +54.4%
Research and Development Expense 8.87M USD +39.7%
Selling and Marketing Expense 15.6M USD +74.1%
General and Administrative Expense 7.88M USD +73.4%
Operating Income (Loss) -19.9M USD -68.6%
Nonoperating Income (Expense) 3M USD
Net Income (Loss) Attributable to Parent -16.9M USD -16.6%
Earnings Per Share, Basic -0.39 USD/shares +83.5%
Earnings Per Share, Diluted -0.39 USD/shares +83.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.1M USD +169%
Accounts Receivable, after Allowance for Credit Loss, Current 11.4M USD
Inventory, Net 17.3M USD
Other Assets, Current 260K USD
Assets, Current 286M USD
Property, Plant and Equipment, Net 6.47M USD
Operating Lease, Right-of-Use Asset 6.04M USD
Other Assets, Noncurrent 144K USD
Assets 330M USD
Accounts Payable, Current 3.42M USD
Employee-related Liabilities, Current 7.62M USD
Liabilities, Current 19.5M USD
Operating Lease, Liability, Noncurrent 5.17M USD
Other Liabilities, Noncurrent 1.01M USD
Liabilities 28.3M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 149K USD
Retained Earnings (Accumulated Deficit) -342M USD
Stockholders' Equity Attributable to Parent 302M USD
Liabilities and Equity 330M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 700M shares
Common Stock, Shares, Issued 43.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.2M USD +168%
Operating Lease, Liability 6.69M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17M USD -17.1%
Lessee, Operating Lease, Liability, to be Paid 8.3M USD
Property, Plant and Equipment, Gross 12.4M USD
Operating Lease, Liability, Current 1.52M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 929K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.53M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.62M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD
Additional Paid in Capital 644M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.8M USD +220%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares